The safety of ALLEGRA for the treatment of chronic idiopathic urticaria in subjects 6 months to 11 years of age is based on cross-study comparison of the pharmacokinetics of ALLEGRA in adult and pediatric subjects and on the safety profile of fexofenadine in both adult and pediatric subjects at doses equal to or higher than the recommended dose. In mice, fexofenadine hydrochloride produced no effect on male Cheap Allegra female fertility at average oral doses up to 4438 mg/kg. Nonteratogenic Effects. ALLEGRA tablets are coated with a peach colored film coating Cheap Allegra . Clinical studies of ALLEGRA tablets and capsules did not include sufficient numbers of subjects aged
Allegra - Fedex Delivery years and over to determine whether this population responds differently from younger subjects. In a placebo-controlled clinical study in the United States, which included 570 subjects aged 12 years and older receiving fexofenadine hydrochloride tablets at doses of 120 or 180 mg once daily, adverse events were similar in fexofenadine hydrochloride- and
Allegra C.O.D. subjects.
In rat fertility studies, dose-related reductions in implants and increases in postimplantation losses were observed at an oral dose Cheap Allegra 150 mg/kg of terfenadine. The effectiveness of ALLEGRA for the treatment of seasonal allergic rhinitis in subjects 6 to 11 years of age was demonstrated in 1 trial (n=411) in which ALLEGRA tablets 30 mg twice daily significantly reduced total symptom scores compared to placebo, along with extrapolation of demonstrated efficacy in subjects aged 12 years and above, and the pharmacokinetic comparisons in adults and children. Other reported clinical experience has not identified differences in responses between the geriatric and younger subjects. Dose-related decreases in pup weight gain and survival were observed in rats exposed to an oral dose of 150 mg/kg of terfenadine (which led to fexofenadine exposures that were approximately 3 times the exposure at the maximum recommended human daily oral dose of 180 mg of fexofenadine hydrochloride based on comparison of AUCs). No evidence of carcinogenicity was observed in an 18-month study in mice and in a 24-month study in rats at oral doses up to 150 mg/kg of terfenadine (which led to fexofenadine exposures that were approximately 3 and 5 times Cheap Allegra exposure at the maximum recommended daily oral dose of fexofenadine hydrochloride in adults [180 mg] and children [60 mg], respectively). In placebo-controlled chronic idiopathic urticaria clinical trials, which included 726 subjects 12 years of age and older receiving fexofenadine hydrochloride tablets at doses of 20 to 240 mg twice daily, adverse events were similar in fexofenadine hydrochloride- and placebo-treated patients. ALLEGRA should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. This is based on the results from 3 clinical studies using histamine induced skin wheals and flares coupled with population
(Ups) Allegra analysis.
The carcinogenic potential of fexofenadine was assessed using terfenadine studies with adequate fexofenadine exposure (based on plasma area-under-the-concentration time [AUC] values). Based on the literature reports, the same effects may be extrapolated to other fruit juices such as apple juice. Because many drugs are excreted in human milk, caution should be exercised when
Allegra(Gen) is administered to a nursing woman. The size of wheal and flare were significantly larger when fexofenadine hydrochloride was administered with either grapefruit or orange juices compared to water. The effectiveness of ALLEGRA for the treatment of chronic idiopathic urticaria in patients 6 months to 11 years of age is based on the pharmacokinetic comparisons in adults and children and an extrapolation of the demonstrated efficacy of ALLEGRA in adults with this condition and the likelihood that the disease course, pathophysiology and the drug’s effect are substantially similar in children to that of adult patients.